Table 10 Baseline, Adult height, & Adult height gain of controls (Mean SDS & 95% CI) in Published Studies of NFSS & FSS and of Treated Children in Our Study
| Â | Baseline | Adult height | Adult height gain | ||||||
|---|---|---|---|---|---|---|---|---|---|
Published study [Ref. #] | Number | mean SDS | (95% CI) | mean SDS | (95% CI) | mean SDS | (95% CI) | ||
NFSS Wit [9] | 45 | -3.20 | -3.35 – - 3.05 | -2.40 | -2.64 – -2.16 | 0.80 | 0.62 – 0.98 | ||
NFSS Albertsson-Wikland [3] | 36 | -2.60 | -2.87 – -2.33 | -2.10 | -2.34 – -1.86 | 0.50 | 0.23 – 0.77 | ||
Our study NFSS (Treated) | 63 | -2.62 | -2.77 – -2.47 | -0.56 | -0.72 – -0.40 | 2.06 | 1.87 – 2.25 | ||
Difference ― Our study to: |  |  |  |  | cm |  | cm | ||
M | F | M | F | ||||||
NFSS Wit[9] | Â | +0.58 | Â | +1.84 | 12.4 | 11.3 | +1.26 | 8.5 | 7.7 |
NFSS Albertsson-Wikland[3] | Â | -0.02 | Â | +1.54 | 10.4 | 9.4 | +1.56 | 10.2 | 9.5 |
FSS Wit [9] | 10 | -2.50 | -2.85 – -2.15 | -2.20 | -2.83 – -1.57 | 0.30 | -0.05 – 0.65 | ||
FSS Albertsson-Wikland [3] | 10 | -2.80 | -3.52 – -2.08 | -2.90 | -3.57 – -2.23 | -0.10 | -0.79 – 0.59 | ||
Our study FSS (Treated) | 25 | -2.59 | -2.86 – -2.32 | -1.08 | -1.41 – -0.75 | 1.51 | 1.24 – 1.78 | ||
Difference ― Our study to: |  |  |  |  | cm |  | cm | ||
M | F | M | F | ||||||
FSS Wit[9] | Â | -0.09 | Â | +1.12 | 7.5 | 6.9 | +1.21 | 8.1 | 7.4 |
FSS Albertsson-Wikland[3] | Â | +0.21 | Â | +1.82 | 12.8 | 11.2 | +1.61 | 10.8 | 9.9 |